Effects of metoclopramide on the paradoxical growth hormone response to galanin in acromegaly.
Galanin is able to enhance growth hormone (GH)-releasing hormone stimulated GH secretion in normal man. In acromegaly circulating GH levels are elevated and the GH response to GHRH may be exaggerated. Galanin has been recently shown to decrease circulating GH levels in acromegaly. Dopaminergic drugs were the only previously known agents able to cause a paradoxical GH fall in acromegaly. Aim of our study was to investigate the effects of a potent central dopaminergic receptor blocker, metoclopramide (MCP), on the galanin-induced paradoxical GH secretion in acromegalic subjects. Two male and three female patients with active acromegaly (age range 44-66 years, body mass index range 24.6-28 Kg/m2) were studied after 45 min i.v. infusion of porcine galanin (0.5 mg in 100 ml of saline) from 0 to 45 min combined with a 60 min i.v. infusion of a) saline (100 ml) or b) MCP (10 mg in 100 ml of saline) from -15 to 45 min. After galanin, GH values fell from baseline (27.5 +/- 10 micrograms/L) to a mean nadir of 16.4 +/- 6.1 micrograms/L; after galanin + MCP, circulating GH levels were also decreased (mean nadir 17.3 +/- 8.1 micrograms/L) in all the patients with respect to baseline (23.6 +/- 9.7 micrograms/L). No significant differences were found in absolute or percent of baseline GH levels after galanin+saline vs galanin + MCP. Our results suggest that the paradoxical GH fall after galanin in acromegalic patients is not mediated through dopaminergic receptor. It can be hypothesized that galanin may interact at the pituitary level with its own receptors expressed by GH-secreting adenomatous cells.
Giustina
A
A
Cattedra di Clinica Medica, University of Brescia, Italy.
Doga
M
M
Bodini
C
C
Bossoni
S
S
Bresciani
E
E
Bussi
A R
AR
D000172:Acromegaly / Q000097:blood* / Q000378:metabolism; D000328:Adult; D000368:Aged; D015992:Body Mass Index; D005260:Female; D019004:Galanin; D013006:Growth Hormone / Q000097:blood* / Q000378:metabolism; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008787:Metoclopramide / Q000008:administration & dosage / Q000494:pharmacology*; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage / Q000494:pharmacology*; D010902:Pituitary Gland / Q000378:metabolism; D011863:Radioimmunoassay; D013997:Time Factors
D010455:Peptides; D019004:Galanin; D013006:Growth Hormone; D008787:Metoclopramide